Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
100 participants
INTERVENTIONAL
2025-09-11
2026-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The objective behind this innovative approach is to empower individuals to discover the potential mental health benefits of integrating a brief period of sunlight exposure into their daily morning routine. By participating in this trial, individuals are not only taking an active step towards potentially enhancing their own mental wellness but are also contributing valuable data to a broader scientific endeavor aimed at validating a cost-free, accessible method for supporting mental health.
This study will utilize a variety of validated tools to rigorously assess changes in participants' emotional states and personal well-being throughout the trial period. This includes tracking shifts in positive affect, stress levels, and overall mood, to determine whether this straightforward daily practice can yield significant improvements in mental health metrics.
The significance of this study lies in its potential to offer a low-cost, universally accessible intervention for enhancing mental wellness without the need for pharmaceuticals, subscriptions, or the risk of adverse side effects. Despite variables such as weather conditions or individual daily routines, the prospect of establishing a free, evidence-based practice for reducing stress and elevating mood holds considerable promise. Through this remotely conducted trial, the investigators aim to gather conclusive evidence on the efficacy of morning sunlight exposure as a tool for mental health support, thereby contributing to the development of simple, natural strategies for managing stress and improving emotional well-being in today's fast-paced world.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single arm where participants act as their own control
Single arm where participants act as their own control
Morning sunlight
Participants are asked to get 15 minutes of morning sunlight every day for 30 days.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Morning sunlight
Participants are asked to get 15 minutes of morning sunlight every day for 30 days.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* US resident.
* Willing and able to follow the requirements of the protocol.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Efforia, Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Efforia
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Additional information and join instructions on Efforia
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
37231
Identifier Type: -
Identifier Source: org_study_id